Trial Profile
The effect of Sorafenib and intermittent hepatic arterial infusion chemotherapy using Cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombus : a phase 1 study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Pharmacokinetics
- 07 Feb 2012 New trial record